Scott Dziengelski

Scott Dziengelski

King & Spalding

Contact
View Bio
RSS

Latest Posts › Draft Guidance

Share:

Administrative, Congressional, and State Interest Signal a Potential Breakthrough Moment for Psychedelics

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, however, psychedelics have garnered scientific and public attention for their potential...more

6/6/2025  /  Clinical Trials , Department of Health and Human Services (HHS) , Draft Guidance , Drug Pricing , FDA Approval , Food and Drug Administration (FDA) , Mental Health , New Legislation , Proposed Legislation , Research and Development
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide